Psagot Value Holdings’s Pfizer PFE Stock Holding History

Psagot Value Holdings’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-5,022	Closed	-$139K	–	88
2024 Q1	$139K	Sell	5,022 -39,150	-89%	-$1.09M	1.26%	29
2023 Q4	$1.27M	Sell	44,172 -1,175	-3%	-$35.5K	0.55%	38
2023 Q3	$1.46M	Buy	45,347 +22,000	+94%	+$778K	0.74%	32
2023 Q2	$847K	Sell	23,347 -18,753	-45%	-$730K	0.43%	50
2023 Q1	$1.69M	Sell	42,100 -58,885	-58%	-$2.54M	0.7%	32
2022 Q4	$5.17M	Buy	100,985 +731	+0.7%	+$35K	1.53%	18
2022 Q3	$4.39M	Sell	100,254 -36,763	-27%	-$1.79M	1.24%	19
2022 Q2	$7.18M	Sell	137,017 -9,754	-7%	-$497K	1.68%	11
2022 Q1	$7.6M	Buy	146,771 +58,574	+66%	+$3.04M	1.67%	14
2021 Q4	$5.21M	Buy	88,197 +58,272	+195%	+$2.89M	1%	26
2021 Q3	$1.29M	Sell	29,925 -82,254	-73%	-$3.64M	0.22%	85
2021 Q2	$4.39M	Sell	112,179 -807	-0.7%	-$31.4K	0.16%	84
2021 Q1	$4.09M	Buy	112,986 +33,690	+42%	+$1.2M	0.09%	130
2020 Q4	$2.92M	Sell	79,296 -40,391	-34%	-$1.48M	0.07%	134
2020 Q3	$4.17M	Buy	119,687 +10,950	+10%	+$384K	0.11%	101
2020 Q2	$3.37M	Sell	108,737 -97,258	-47%	-$3.3M	0.09%	97
2020 Q1	$6.38M	Sell	205,995 -4,901	-2%	-$167K	0.26%	73
2019 Q4	$7.84M	Buy	210,896 +912	+0.4%	+$32.5K	0.27%	81
2019 Q3	$7.16M	Sell	209,984 -629	-0.3%	-$22.9K	0.29%	79
2019 Q2	$8.66M	Buy	210,613 +2,693	+1%	+$107K	0.35%	72
2019 Q1	$8.38M	Sell	207,920 -3,903	-2%	-$156K	0.35%	69
2018 Q4	$8.77M	Buy	211,823 +24,110	+13%	+$1M	0.4%	64
2018 Q3	$7.85M	Buy	187,713 +5,111	+3%	+$197K	0.35%	65
2018 Q2	$6.29M	Sell	182,602 -720	-0.4%	-$24.6K	0.29%	63
2018 Q1	$6.17M	Sell	183,322 -9,808	-5%	-$337K	0.27%	69
2017 Q4	$6.64M	Buy	193,130 +2,478	+1%	+$84.5K	0.29%	59
2017 Q3	$6.46M	Sell	190,652 -15,201	-7%	-$489K	0.27%	60
2017 Q2	$6.56M	Buy	205,853 +2,317	+1%	+$73.1K	0.28%	57
2017 Q1	$6.61M	Sell	203,536 -2,869	-1%	-$90.5K	0.28%	55
2016 Q4	$6.36M	Buy	206,405 +1,593	+0.8%	+$48.6K	0.27%	55
2016 Q3	$6.58M	Sell	204,812 -17,898	-8%	-$598K	0.28%	54
2016 Q2	$7.44M	Sell	222,710 -34,536	-13%	-$1.1M	0.32%	48
2016 Q1	$7.23M	Sell	257,246 -7,652	-3%	-$219K	0.3%	70
2015 Q4	$8.11M	Sell	264,898 -35,992	-12%	-$1.13M	0.29%	69
2015 Q3	$8.97M	Sell	300,890 -265,809	-47%	-$8.52M	0.33%	61
2015 Q2	$18M	Sell	566,699 -1,294	-0.2%	-$42.2K	0.57%	45
2015 Q1	$18.7M	Sell	567,993 -177,766	-24%	-$5.65M	0.59%	45
2014 Q4	$22M	Buy	745,759 +24,168	+3%	+$693K	0.75%	38
2014 Q3	$20.2M	Buy	721,591 +422,975	+142%	+$11.9M	0.68%	44
2014 Q2	$8.41M	Sell	298,616 -15,714	-5%	-$448K	0.28%	55
2014 Q1	$9.58M	Buy	314,330 +11,681	+4%	+$348K	0.32%	55
2013 Q4	$8.79M	Sell	302,649 -818,421	-73%	-$23.8M	0.31%	54
2013 Q3	$30.6M	Buy	1,121,070 +42,618	+4%	+$1.16M	1.15%	31
2013 Q2	$28.7M	Buy	+1,078,452	New	+$29.8M	1.21%	26

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Psagot Value Holdings's PFE Position: Q2 2024 in Review

Psagot Value Holdings sold out of Pfizer (PFE) in Q2 2024, closing a stake of 5,022 shares — an estimated $139K sold.

Psagot Value Holdings first reported a position in PFE in Q2 2013 and held it in 44 quarters. The position peaked at $30.6M in Q3 2013. 2,873 funds tracked by Wall St. Rank hold PFE as of Q2 2024.

Psagot Value Holdings reported no remaining Pfizer position as of Q2 2024 after selling out during the quarter.
Psagot Value Holdings sold 5,022 Pfizer shares in Q2 2024, an estimated $139K.
Psagot Value Holdings first reported a position in Pfizer in Q2 2013 and held it in 44 quarters.
Psagot Value Holdings's Pfizer position peaked at $30.6M in Q3 2013.
2,873 funds tracked by Wall St. Rank held Pfizer as of Q2 2024.

Based on Psagot Value Holdings's 13F filing for Q2 2024.